In October 2025, DIVAMICS officially joined Johnson & Johnson’s Global Incubator Network — JLABS Shanghai. JLABS is a leading global life science innovation incubator that enables an open R&D ecosystem designed to support innovators in accelerating technologies and solutions that improve human health and generate long-term value for patients worldwide. Operating across pharmaceuticals, medical devices, consumer health, and medical technologies, JLABS provides early-stage companies with a compliant, secure laboratory environment and access to a global resources network to facilitate the translation of breakthrough scientific discoveries.

“We are honored to have been selected to join Johnson & Johnson’s Global Incubator Network — JLABS Shanghai, and we appreciate the recognition extended to DIVAMICS. Becoming a resident company at JLABS will provide us with a compliant and secure environment for research and translation, enabling us to advance our early drug discovery programs—particularly the progression from Hits (initial active molecules) to PCC (preclinical candidate compounds)—with greater efficiency. Leveraging the global JLABS network will further strengthen our ability to connect with international partners and explore more possibilities.”

About DIVAMICS

DIVAMICS is an early-stage drug discovery company built on core technologies in artificial intelligence, quantum mechanics, and molecular simulation algorithms. From its inception, the company has positioned itself to serve global markets. Its proprietary Divamics multi-scale molecular dynamics platform and Biotrajectory database, together with its original “Molecular Movie” drug design concept, enable AI-driven, end-to-end Hits-to-PCC drug discovery services for biopharmaceutical companies.

DIVAMICS has worked with more than 50 pharmaceutical industry clients worldwide, supporting over 80 drug discovery pipelines. The company is headquartered in Suzhou, with a computing center in Beijing and a business development center in Singapore.

About JLABS Shanghai

Opened in 2019, JLABS Shanghai is the largest JLABS site globally by footprint under Johnson & Johnson Innovation and the first JLABS location in the Asia-Pacific region. Situated in Shanghai’s Zhangjiang Hi-Tech Park, the facility spans more than 4,400 square meters and was jointly established by Zhangjiang Pharma Valley Public Service Platform Co., Ltd. and Johnson & Johnson Innovation. JLABS Shanghai can host approximately 50 resident companies across pharmaceuticals, medical devices, consumer products, and medical technologies.

(Address: South Tower, Building 1, Jinchuang Mansion, No. 4560 Jinke Road, Pudong New Area, Shanghai)

If you would like to learn more about how DIVAMICS leverages AI and molecular dynamics simulation technologies to accelerate early-stage drug discovery and translational research, you are welcome to leave a message via the official “DIVAMICS” WeChat account or contact us at bd@szdeepdynamics.com to arrange a visit to JLABS Shanghai.